March 2007
|Volume 19 Issue 3
Case Report. A 50-year-old Caucasian male with no significant past medical history presented to our institution with sudden onset of shortness of breath. He admitted to having exertional chest pressure and shortness of breath for a few years. His ris…
Chronic total occlusions (CTO) remain one of the most technically challenging areas of coronary intervention. As a result, new innovative techniques are continually being developed in an effort to improve the procedural success rate of CTO recanaliza…
We’re going to move on to the second session entitled: Contemporary Prevention, Management and Treatment of Stroke — Who Will Treat Acute Stroke in 2010 and How Will It Be Treated?The data on this first slide (Figure 1) show the magnitude of the prob…
I’m going to give you a perspective on where we see the current state of carotid artery stenting from the regulatory and reimbursement perspectives, and perhaps a bit of technical unmet needs and future prospects. Obviously, this is going to be larg…
First of all, I would like to thank the organizers of this meeting, particularly Dr. Michael Cowley, who asked me to attend. It’s an honor to be here. As a biochemist who has spent most of his life with his head in the “cell-culture” neighborhood, it…
When I think about the way we treat carotid disease, I see a great example of multiple specialties that are not working together. Everybody has something to offer the specialty of carotid stenting, and everybody, in my view, needs to possess the foll…
David Holmes really set the stage with his discussion, but let me also summarize what stroke means today. After suffering a major stroke, one-third of patients will recover, one-third will die, and one-third will be wrecked; it’s the latter group tha…
We thank (the authors of the letter) for their comments about our study in the Journal,1 and it seems they essentially agree with our conclusions. However, they raise some specific points to add weight to the argument that the main reason we did not…
The recently FDA-approved Tornus® penetration catheter (Asahi Intecc, Aichi, Japan) has been shown to be effective in the treatment of severe coronary artery lesions and chronic total occlusions when they are first crossed by coronary guidewires but…
Case Report. A 75-year-old male presented to our catheterization laboratory with exertional shortness of breath (Canadian Cardiovascular Society Class 2–3) and a positive dipyridamole nuclear scan with ischemia in the infero-lateral territory which w…